Article info

PDF

Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

Authors

  1. Correspondence to Dr Bruno Rodrigues Rosa; eubrunorosa{at}gmail.com
View Full Text

Citation

Rosa BR, Cunha AJLAD, Medronho RDA
Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

Publication history

  • Received March 16, 2018
  • Revised December 19, 2018
  • Accepted December 20, 2018
  • First published March 13, 2019.
Online issue publication 
March 13, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.